top of page
Anti-SALL4 (clone QR024)

Anti-SALL4 (clone QR024)

SALL4 – A Key Transcription Factor and Cancer Marker

The SALL Protein Family and SALL4 Function

✔ The human body expresses four SALL proteins: SALL1, SALL2, SALL3, and SALL4, which share structural homology and play diverse roles in:

  • Embryonic development
  • Kidney function
  • Oncogenesis

SALL4 (Sal-like protein 4) is a zinc-finger transcription factor that:

  • Maintains pluripotency in stem cells
  • Interacts with other pluripotency factors, such as OCT4 and NANOG

SALL4 as a Marker for Germ Cell Tumors

✔ Due to its expression in germ cells, SALL4 serves as a valuable marker in the diagnosis of germ cell tumors, including:

  • Seminoma
  • Embryonal carcinoma
  • Yolk sac tumor
  • Teratoma

SALL4 and Prognosis in Cancer

SALL4 expression is often associated with poor survival and prognosis, for example, in:

  • Hepatocellular carcinoma (HCC)

✔ In other malignancies, SALL4 overexpression is linked to metastasis, such as in:

  • Endometrial carcinoma
  • Colorectal carcinoma (CRC)
  • Esophageal squamous cell carcinoma

SALL4 Expression in Adult Cancers

✔ In most adult tissues, SALL4 levels are low or undetectable (except in germ cells and hematopoietic progenitor cells).
✔ However, reactivation and dysregulated expression of SALL4 occur in various malignancies, including:

  • Acute myeloid leukemia (AML)
  • B-cell acute lymphoblastic leukemia (B-ALL)
  • Gastric cancer
  • Breast cancer
  • Hepatocellular carcinoma (HCC)
  • Lung cancer
  • Gliomas

Summary

SALL4 is a key transcription factor involved in pluripotency and oncogenesis.
It serves as a useful marker for germ cell tumors, including seminoma, embryonal carcinoma, yolk sac tumor, and teratoma.
High SALL4 expression correlates with poor prognosis and metastasis in several malignancies, such as HCC, endometrial carcinoma, and colorectal carcinoma.
While its expression is low in adult tissues, SALL4 reactivation is observed in various cancers, including AML, B-ALL, gastric, breast, lung cancers, and gliomas.

    bottom of page